Not for retail sale medicaments with penicillins or streptomycins market in Italy

Earlier Report Observations

From 2018 to 2021, the market for non-retail penicillin and streptomycin medicaments in Italy experienced significant volatility. The total market size fell from 91 791 thousand US dollars in 2018 to 64 343 thousand in 2019, recovered to 75 372 thousand in 2020, then dropped sharply to 40 428 thousand in 2021. Domestic production mirrored this instability, declining to 18 366 thousand dollars in 2021, while import and export volumes also contracted substantially over the period.

After a brief rebound in 2022, both imports and exports entered a sustained decline through 2024. Imports fell from 39 983 thousand dollars in 2022 to 23 963 thousand in 2024, and exports decreased from 13 325 thousand to 7 960 thousand. This downward trend aligned with the post-pandemic epidemiological stabilization, which reduced overall demand for antibiotic treatments. Furthermore, regulatory interventions by the Italian Medicines Agency (AIFA), including updates to the list of medicines guaranteed for national distribution and authorizations for extraordinary imports of scarce drugs, directly influenced market access and altered trade flows.

Production not for retail sale medicaments with penicillins or streptomycins in Italy

In value, 2017-2020, K $ US

In 2020, Italy's production of not-for-retail-sale medicaments containing penicillins or streptomycins reached a value of 53 106 thousand US dollars, marking a substantial 24.2% increase from the previous year. The lowest production value was recorded in 2019 at 42 745 thousand US dollars, which saw the largest decline of 17.8%. Over the period from 2017 to 2020, overall production grew by 5.8%, translating to an annualized growth rate of 1.9%.

Annual dynamics of production in Italy in value, 2017-2020, K $ US

Exports not for retail sale medicaments with penicillins or streptomycins from Italy

Exports in kind, kg

Italy's exports of not-for-retail-sale medicaments containing penicillins or streptomycins declined for the second consecutive year. In 2020, exports totaled 64 840 kilograms, showing no significant change from 2019. The peak export volume was recorded in 2018 at 73 402 kilograms, which also saw the largest increase of 6.8%. The largest decline occurred in 2019 with an 11.6% drop. From 2017 to 2020, exports decreased by 5.6%, with a compound annual growth rate of -1.9%.

Annual dynamics of product's exports from Italy in kind, 2017-2020, kg

Between 2017 and 2020, Italy's export portfolio for not-for-retail-sale medicaments containing penicillins or streptomycins was diverse. Poland accounted for 21.1% of exports in volume, Hungary for 11.7%, and Germany for 11.1%. Together, these three countries represented 44.0% of total exports, while numerous other countries held smaller but notable shares.

Structure of product's exports in kind by countries, 2017-2020

World map of product's exports from Italy in kind, 2017-2020

Exports in value, K $ US

Italy's export value of not-for-retail-sale medicaments containing penicillins or streptomycins declined for the third consecutive year. In 2020, exports amounted to 7 471 thousand US dollars, reflecting a sharp 29.7% decrease from the previous year. From 2017 to 2020, export value fell by 57.1%, with a compound annual growth rate of -24.6%.

Annual dynamics of product's exports from Italy in value, 2017-2020, K $ US

From 2017 to 2020, Germany, Czechia, and Hungary emerged as the primary markets for Italy's exports of not-for-retail-sale medicaments containing penicillins or streptomycins in value terms. Germany accounted for 34.9% of export value, Czechia for 25.9%, and Hungary for 14.7%. Collectively, these three countries represented 75.6% of total export flows.

Structure of product's exports in value by countries, 2017-2020

World map of product's exports from Italy in value, 2017-2020

Imports not for retail sale medicaments with penicillins or streptomycins to Italy

Imports in kind, kg

In 2020, Italy's imports of not-for-retail-sale medicaments containing penicillins or streptomycins totaled 41 090 kilograms, showing minimal change from 2019. The lowest import volume was recorded in 2019 at 40 961 kilograms, which also experienced the largest decline of 38.3%. The peak import volume occurred in 2018 at 66 438 kilograms, with the largest increase of 3.0% that year. Over the period from 2017 to 2020, imports decreased by 36.3%, equating to an annualized decline rate of 13.9%.

Annual dynamics of product's imports to Italy in kind, 2017-2020, kg

Between 2017 and 2020, Belgium dominated Italy's imports of not-for-retail-sale medicaments containing penicillins or streptomycins in volume, accounting for 77.2% of total imports. The remaining imports were distributed among a broad group of smaller countries.

Structure of product's imports in kind by countries, 2017-2020

World map of product's imports to Italy in kind, 2017-2020

Imports in value, K $ US

Italy's import value of not-for-retail-sale medicaments containing penicillins or streptomycins declined for the second consecutive year. In 2020, imports were valued at 29 737 thousand US dollars, reflecting a moderate 7.7% drop from the previous year. The highest import value was recorded in 2018 at 54 346 thousand US dollars, which also saw the largest increase of 19.3%. The largest decline occurred in 2019 with a 40.7% decrease. From 2017 to 2020, import value fell by 34.7%, with a compound annual growth rate of -13.2%.

Annual dynamics of product's imports to Italy in value, 2017-2020, K $ US

From 2017 to 2020, the import market for not-for-retail-sale medicaments containing penicillins or streptomycins in Italy was highly concentrated. Belgium alone was responsible for 92.6% of total import value.

Structure of product's imports in value by countries, 2017-2020

World map of product's imports to Italy in value, 2017-2020